Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor, Adult × Trastuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 493 Stomach Neoplasms 54 Neoplasm Metastasis 46 Neoplasms 31 HER2-positive Breast Cancer 26 Breast Neoplasms, Male 26 Colorectal Neoplasms 23 Esophageal Neoplasms 19 Brain Neoplasms 19 Carcinoma, Non-Small-Cell Lung 17 Inflammatory Breast Neoplasms 15 Triple Negative Breast Neoplasms 11 Pancreatic Neoplasms 10 Endometrial Neoplasms 9 Colonic Neoplasms 9 Rectal Neoplasms 8 Ovarian Neoplasms 8 Adenocarcinoma Of Esophagus 7 Adenocarcinoma 7 Urinary Bladder Neoplasms 6 Sarcoma 6 Salivary Gland Neoplasms 6 Prostatic Neoplasms 6 Pathologic Complete Response 6 Lung Neoplasms 6 Gallbladder Neoplasms 6 Biliary Tract Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Breast Diseases 5 Recurrence 4

Interventions

pembrolizumab 5 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 niraparib 1 neotil 1 necitumumab 1 leronlimab 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Yoga 1 Valganciclovir 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04092673 2024-05-21

Zotatifin

Effector Therapeutics

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡